MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2022 International Congress

    Safety of incobotulinumtoxinA in pediatrics: A pooled analysis

    F. Heinen, M. Banach, E. Dabrowski, D. Gaebler-Spira, H. Chambers, S. Schroeder, T. Geister, M. Althaus, A. Hanschmann, S. Berweck (Munich, Germany)

    Objective: To present analyses of pooled data on the safety of incobotulinumtoxinA (INCO) in pediatrics Background: BotulinumtoxinA (BoNT-A) is used to treat several conditions affecting…
  • 2022 International Congress

    Botulinum Toxin A in the Management of peripheral mononeuropathy: post herpetic neuralgia and trigeminal neuralgia

    F. Ortega (guatemala, Guatemala)

    Objective: The purpose of this study is determinate the efficacy and safety of botulin toxin A in the treatment of refractory post herpetic neuralgia and…
  • 2022 International Congress

    Therapeutic approach to botulinum injections for hemifacial spasm, post facial paralysis synkinesis and blepharospasm

    G. Yahalom, A. Janah, R. Eichel (Jerusalem, Israel)

    Objective: To show our therapeutic outcome of botulinum injection to the facial muscles and thereby to find the best therapeutic concept which should be embraced.…
  • 2022 International Congress

    Botulinum toxin injections are an effective treatment for patients with essential head tremor.

    A. Marques, I. Rieu, B. Pereira, G. Castelnovo, F. Fluchère, C. Laurencin, B. Degos, A. Poujois, A. Kreisler, S. Sangla, M. Tir, I. Benatru, G. Blanchet-Fourcade, D. Guehl, D. Gayraud, L. Tatu, C. Tranchant, D. Amarantini, M. Simonetta, F. Durif (Clermont-Ferrand, France)

    Objective: To assess the safety and efficacy of Botulinum toxin (Btx) injections in essential head tremor (HT) in a multicenter, randomized, double blind, parallel-group, placebo-controlled…
  • 2022 International Congress

    IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: a real-life study

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, H. Couckuyt, M. van Zandijcke (Bruges & Ghent, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles (IC) into…
  • 2022 International Congress

    Botulinum neurotoxin simulation workshop: Impact on resident satisfaction and knowledge

    C. Selvadurai, E. Cournean, N. Prakash, B. Rodrigues (Farmington, USA)

    Objective: To assess resident satisfaction and knowledge after a hands-on Botulinum toxin (BoNT) simulation workshop (SW). Background: Despite having an application for BoNT in almost…
  • 2022 International Congress

    Limb myorhythmia treated with chemodenervation: A case report

    N. Saez Calveras, M. Bryarly, M. Salinas (Dallas, USA)

    Objective: To describe the case of a patient with limb myorhythmia successfully treated with bolutinum toxin injections. Background: Myorhythmia is a rare condition characterized by…
  • 2022 International Congress

    Hypersensitive reaction to botulinum toxin type A following Covid19 mRNA vaccination

    VL. Livneh, L. Barsky, H. Shabtai, A. Ezra, T. Gurevich (Tel Aviv, Israel)

    Objective: two cases of hypersensitivity reactions to botulinum toxin type A (BTA) following mRNA based COVID-19 vaccine Background: Botulinum toxin type A is  widely used…
  • MDS Virtual Congress 2021

    Efficacy of Incobotulinumtoxin/A Treatment for Children/Adolescents with Sialorrhea associated with Neurological Disorders

    S. Berweck, H. Kim, M. Banach, A. Hanschmann, M. Althaus, M. Bonikowski (Vogtareuth, Germany)

    Objective: The SIPEXI (Sialorrhea Pediatric Xeomin Investigation) study investigated efficacy and safety of intraglandular incobotulinumtoxinA (incoBoNT/A) injections in children/adolescents with sialorrhea associated with neurological disorders…
  • MDS Virtual Congress 2021

    Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up

    C. Borrue, C. Jimeno (Madrid, Spain)

    Objective: Investigate the safety and efficacy of botulinum toxin type A in Parkinson´s disease and parkinsonism patients affected by sialorrhea Background: Sialorrhea is excessive salivation…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 13
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley